Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
SRPT
SRPT
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
SRPT News
Transformation of Value in Biotechnology Sector
6h ago
Globenewswire
Biotechnology Sector Undergoes Value Transformation
6h ago
Newsfilter
Roche Initiates New Phase 3 Trial for Elevidys Gene Therapy
4d ago
seekingalpha
Capricor's Former Executive Considered for FDA Biologics Chief
6d ago
stocktwits
SAREPTA THERAPEUTICS INC: RBC Increases Target Price from $18 to $19
Apr 07 2026
moomoo
SAREPTA THERAPEUTICS, INC.: DEUTSCHE BANK INCREASES TARGET PRICE FROM $12 TO $14
Mar 26 2026
moomoo
SAREPTA THERAPEUTICS INC: WEDBUSH INCREASES TARGET PRICE FROM $29 TO $35
Mar 26 2026
moomoo
SAREPTA THERAPEUTICS INC: CITIGROUP INCREASES TARGET PRICE FROM $9 TO $13
Mar 26 2026
moomoo
SAREPTA THERAPEUTICS INC: PIPER SANDLER INCREASES TARGET PRICE FROM $16 TO $23
Mar 26 2026
moomoo
Sarepta's Promising Data Sparks Market Optimism
Mar 25 2026
stocktwits
SRPT Stock Sees Largest Daily Increase in Almost 8 Years Following Rare Muscle Disorders Study, Yet Wall Street Remains Skeptical
Mar 25 2026
stocktwits
Sarepta Reports Promising Clinical Results for siRNA Programs
Mar 25 2026
NASDAQ.COM
Precious Metals Stocks Surge, Led by Aura Minerals
Mar 25 2026
NASDAQ.COM
Sarepta Shares Jump 30% Following Gene Therapy Trials, But Safety Concerns Persist.
Mar 25 2026
Barron's
Sarepta Shares Jump 29% Following Gene Therapy Trials, But Safety Concerns Persist.
Mar 25 2026
Barron's
Sarepta Therapeutics Shares Surge 25% on Promising Clinical Trial Data
Mar 25 2026
seekingalpha
Show More News
